ReviewGastroenterology report2026

Tumor-microenvironment-mediated immune escape drives trastuzumab resistance in HER2-positive gastric cancer.

Huifang Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.